Sutro Biopharma, Inc. (STRO) Social Stream



Sutro Biopharma, Inc. (STRO): $7.11

-0.24 (-3.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SUTRO BIOPHARMA INC (STRO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering STRO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 6 $37 $29 $34.2 $7.24 372.38%
2021-12-05 7 $37 $29 $33.5 $7.24 362.71%
2022-05-09 7 $37 $29 $32.333 $7.24 346.59%
2022-05-10 7 $37 $20 $30.666 $7.24 323.56%
2022-05-11 7 $37 $20 $29.833 $7.24 312.06%
2022-05-23 7 $37 $14 $26.285 $7.24 263.05%
2022-08-10 7 $37 $16 $26.571 $7.24 267%
2022-08-18 8 $37 $15 $25.125 $7.24 247.03%
2022-11-09 8 $33 $15 $23.125 $7.24 219.41%
2023-01-10 7 $33 $15 $21 $7.24 190.06%
2023-01-13 7 $33 $15 $21.571 $7.24 197.94%

The Trend in the Analyst Price Target


STRO's average price target has moved down $11.14 over the prior 17 months.

Over the past 45 weeks, STRO's average upside potential has been 290.34%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-10 7 37 20 30.666 5.33 475.35%
2022-05-11 7 37 20 28.428 4.93 476.63%
2022-08-10 7 37 16 26.571 6.73 294.81%
2022-11-09 8 33 15 20.714 7.34 182.21%
2022-11-09 6 33 15 21.875 7.34 198.02%

STRO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


Over the past 14 months, STRO's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • SUTRO BIOPHARMA INC's upside potential (average analyst target price relative to current price) is greater than 1412.51% of all US stocks.
  • In the context of all US stocks, SUTRO BIOPHARMA INC's variance in analysts' estimates is lower than -990.15% of them.
  • In the context of stocks in the small market cap category, SUTRO BIOPHARMA INC's number of analysts covering the stock is greater than 1370.48% of them.
  • In terms of how SUTRO BIOPHARMA INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1031.08% of that group.

Stocks similar to SUTRO BIOPHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AUTL, AVRO, and MGTX.

What is the outlook for STRO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6111 seconds.